Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-30
1997-09-02
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 536 2721, 536 276, 536 2761, 536 2762, 536 2763, 536 277, 536 278, 536 2781, A61K 3170, C07H 1916
Patent
active
056631553
ABSTRACT:
The invention relates to compositions comprising an adenosine derivative and a deaminase inhibitor for the prevention and treatment of parasitic infections by eukaryotic organisms. Parasitic infections which are treatable and preventable with these compositions include malaria, trypanosomiasis, leishmania, toxoplasmosis, sarcocystis, pneumocystis, schistosomiasis, blood flukes and elephantiasis. The invention also relates to methods for utilizing these compositions in treatment regiments. Treatments may be either in vivo or in vitro. In vivo treatments involve administration of compositions of the invention to mammals suspected or at risk of being infected with a parasitic organism. In vitro treatments involve incubation of cells, tissues, biological products derived from living materials or foods with compositions of the invention to inhibit or prevent further infection.
REFERENCES:
patent: 4997818 (1991-03-01), McCaffrey et al.
patent: 5180714 (1993-01-01), Sufrin et al.
patent: 5292725 (1994-03-01), Frendergast
Abstract--"Cordycepin Activates An Apoptotic Cascade in TdT-Positive Leukemia Cells," McCaffrey, The American Society of Hematology, 35th Annual Meeting, Dec. 3-7, 1993.
Abstract--"Cordycepin Is Selectively Cytotoxic For TdT-Positive Cells," Yener Koc, The American Society of Hematology, 35th Annual Meeting, 1992.
Abstract--"Cordycepin Selectively Kills TdT-Positive Cells," Yener Koc, The American Society of Hematology, 35th Annual Meeting, 1993.
Abstract--"Induction of Apoptosis In TdT Leukemia/Lymphoma Cells By Cordycepin (3'-dA)," Yener Koc, ASCO Annual Meeting, May 14-17, 1994.
"Adenosine Analogues As Antimetabolites Against Plasmodium FalciparumMalaria," Coomber, et al., International Journal of Parasitology, vol. 24, No. 3, pp. 376-365, 1994.
"Adenosine Deaminase From Human Erythrocytes: Purification and Effects of Adenosine Analogs," Agarwal, et al., Biochemical Pharmacology, vol. 24, pp. 693-701, 1975.
"Antimalarial Action of Nitorbenzylthioinosine in Combination with Purine Nucleoside Antimetabolites," Gero, et al., Moloecular and Biochemical Parasitology, vol. 34, pp. 87-98, 1989.
"Biochemistry of Plasmodium (Malarial Parasites)," Sherman, Microbiological Reviews, vol. 43, No. 4, pp. 453-495, Dec. 1979.
"Characterization of Adenosine Deaminase From the Malarial Parasite, Plasmodium Lophurae, and Its Host Cell, The Duckling Erythrocyte", Schimandle, et al., Biochemical Pharmacology, pp. 115-121, 1983.
"Enzymes of Purine and Pyrimidine metabolism From the Human Malaria Parasite, Plasmodium Falciparum," Reyes, et al., Molecular and Biochemical Parasitology, vol. 5, pp. 275-290, 1982.
"Human Melanoma Cells Sensitive To Deoxyadenosine and Deoxyinosine," Parsons, et al., Biochemical Pharmacology, vol. 35, No. 4, pp. 655-660, 1986.
"Human Malaria Parasite Adenosine Deaminase, Characterization in Host Enzyme-Deficient Erythrocyte Culture," Daddona, et al., The Journal of Biological Chemistry, vol. 259, No. 3, pp. 1472-1475, Feb. 10, 1984.
"Incorporation of 2-Halogeno-2'-Deoxyadenosine 5-Triphosphates into DNA During Replication by Human Polymerases .alpha.and .beta.," Hentosh, et al., The Journal of Biological Chemistry, vol. 265, No. 7, pp. 4033-4040, Mar. 5, 1990.
"In Vitro Susceptibilities of Plasmodium Falciparum to Compounds Which Inhibit Nucleotide Metabolism," Queen, et al., Antimicrobial Agents and Chemotheraphy, vol. 34, No. 7, pp. 1393-1398, Jul. 1990.
"Metabolism of Adenosine Analogues By Schistosoma Mansoni and the Effect of Nuceloside Transport Inhibitors," Kouni, et al., Biochemical Pharmacology, vol. 36, No. 7, pp. 1099-1106, 1987.
"On the mechanism of feedback Inhibition of Purine Biosynthesis de Novo in Ehrlich Ascites Tumor Cells in Vitro," Henderson, et al., The Journal of Biological Chemistry, vol. 240, No. 7, Jul. 1965.
"Purine and Pyrimidine Metabolism in the Trypanosomatidae," Hammond, et al., Molecular and Biochemical Parasitiology, vol. 13, pp. 243-261, 1984.
"Purine Nucleoside Phosphorylase of the Malarial Parasite, Plasmodium Lophurae, " Schimandle, et al., The Journal of Biological Chemistry, vol. 260, No. 7, pp. 4455-4460, Apr. 10, 1985.
"Purines and Pyrimidines in Malarial Parasites," Gero, et al., Blood Cells, vol. 16, pp. 467-484, 1990.
"Purine Salvage and Metabolism in Babesia Bovis," Matias, et al., Parasitol Res., vol. 76, pp. 207-213, Feb. 1990.
"Pryimidine Analogues," Hochster, et al., Metabolic Inhibitors, A Comprehensive Treatise, vol. 1, pp. 239-285, 1963.
"Quantitative Assessment of Antimalarial Activity In Vitro by a Semiautomated Microdilution Technique," Desjardins, et al., Antimicrobial Agents and Chemotheraphy, vol. 16, No. 6, pp. 710-718, Dec. 1979.
"Selective Toxicity of Deoxyadenosine Analogues In Human Melanoma Cell Lines," Parsons, et al, Biochemical Pharmacology, vol. 35, No. 22, pp. 4025-4029, Nov. 15, 1986.
"Stage-Specific alteration of Nucleoside Membrane Permeability and Nitrobenzylthioinosine Insensitivity in Plasmodium Falciparum Infected Erythrocytes," Gero, et al., Molecular and Biochemical Parasitology, vol. 27, pp. 159-170, Jan. 1988.
"Synchronization of Plasmodium Falciparum Erythrocytic Stages in Culture," Lambros, et al., J. Parasitol, vol. 65, No. 3, pp. 418-420, 1979.
"The Toxicity of Adenosine Analogues Against Babesia Bovis In Vitro," Journal for Parasitology, vol. 21, No. 6, pp. 747-751, 1991.
Abstract--Johns, et al., "Enhancement of the Biological Activity of Cordycepin (3'Deoxyadenosine) by the Adenosine Deaminase Inhibitor 2'-Deoxycoformycin", Biochem. Pharmacol., vol. 25, No. 12, Oct. 11, 1976.
Abstract--Adamson, et al. "Enhancement of the Biological Activity of Adenosine Analogs by the Adenosine Deaminase Inhibitor 2'-Deoxycoformycin",Pharmocology, vol. 15, No. 1, May 9, 1977.
Abstract--Yamasa Shoyu KK "Cordycepin and (2')-deoxycoformicin prepd, simultaneously by culturing a strain of Aspergillus or Emericella" JP,A,52 130 991, Nov. 2, 1977.
Moorman et al., "Antiprotozoal Activity of 3'-Deoxinosine," Biochemical Pharmacology, vol. 42, No. 2, pp. 207-212, (1991).
McCaffrey Ronald P.
Wigzell Hans L. R.
Remenick James
The University Hospital
Wilson James O.
LandOfFree
Compositions for the treatment of parasitic infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the treatment of parasitic infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment of parasitic infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308178